Portage Biotech (PRTG) Earnings Date, Estimates & Call Transcripts

$0.24
-0.01 (-4.05%)
(As of 04/25/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jul. 29Estimated
Actual EPS
(Feb. 28)
-$0.18 Beat By $0.09
Consensus EPS
(Feb. 28)
-$0.27
Skip Charts & View Estimated and Actual Earnings Data

PRTG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRTG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Portage Biotech Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.25)($0.25)($0.25)
Q2 20241($0.27)($0.27)($0.27)
Q3 20242($0.28)($0.26)($0.27)
Q4 20242($0.22)($0.21)($0.22)
FY 20246($1.02)($0.99)($1.01)

PRTG Earnings Date and Information

Portage Biotech last released its earnings data on February 28th, 2024. The reported ($0.18) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.09. Portage Biotech has generated ($8.34) earnings per share over the last year (($8.34) diluted earnings per share). Earnings for Portage Biotech are expected to grow in the coming year, from ($1.03) to ($0.65) per share. Portage Biotech has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off prior year's report dates.

Portage Biotech Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/29/2024
Estimated)
------- 
2/28/2024Q3 2024($0.27)($0.18)+$0.09$1.52--
11/29/2023Q3 2023($0.27)($0.29)($0.02)($0.29)--
8/30/2023Q2 2023($0.24)($0.33)($0.09)($0.33)--
7/31/2023Q4 2023-($5.84)($5.84)($5.84)--
3/1/2023Q3 2023($0.23)($0.44)($0.21)($0.44)--
11/29/2022Q2 2023($0.27)($0.06)+$0.21($0.06)--
8/29/2022Q1 2023($0.35)($0.13)+$0.22($0.13)--
8/1/2022Q4 2022-($0.55)($0.55)($0.55)--
2/24/2022Q3 2022($0.28)($0.26)+$0.02($0.26)--
11/22/2021Q3 2021($0.25)($0.22)+$0.03($0.22)--
8/30/2021Q1 2022-($0.25)($0.25)($0.25)--

Portage Biotech Earnings - Frequently Asked Questions

When is Portage Biotech's earnings date?

Portage Biotech has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 29th, 2024 based off last year's report dates. Learn more on PRTG's earnings history.

Did Portage Biotech beat their earnings estimates last quarter?

In the previous quarter, Portage Biotech (NASDAQ:PRTG) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.09. Learn more on analysts' earnings estimate vs. PRTG's actual earnings.

How much profit does Portage Biotech generate each year?

Portage Biotech (NASDAQ:PRTG) has a recorded net income of -$104.61 million. PRTG has generated -$8.34 earnings per share over the last four quarters.

What is Portage Biotech's EPS forecast for next year?

Portage Biotech's earnings are expected to grow from ($1.03) per share to ($0.65) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:PRTG) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners